Selank: Anxiety, Cognitive Balance and the Neuroscience Behind It

Selank is a synthetic heptapeptide with anxiolytic effects — and unusually for an anti-anxiety compound, it does not produce sedation or cognitive impairment. This profile makes it of considerable interest in contexts where mental clarity and stress resilience are priorities.

By UAE Peptide Clinic Research Desk

Selank is a synthetic heptapeptide developed in Russia as a derivative of the endogenous tetrapeptide tuftsin. It has been studied and clinically used for more than two decades, primarily for its anxiolytic (anti-anxiety) effects — and unusually for a compound with anxiolytic action, it does not produce sedation or cognitive impairment. This profile makes it of considerable interest in contexts where mental clarity and stress resilience are priorities.

Mechanism of Action

Selank acts through multiple neurological pathways. It appears to modulate the GABAergic system — the primary inhibitory neurotransmitter system — without acting directly as a GABA receptor agonist. This distinguishes it from benzodiazepines and accounts for its absence of dependence, sedation, and withdrawal effects. It also influences brain-derived neurotrophic factor (BDNF) expression, serotonin turnover, and the enkephalin system.

Clinical Applications

Selank is used in physician-supervised protocols for anxiety management, stress resilience, and cognitive performance under pressure. It is often considered for patients in high-demand professional environments where conventional anxiolytics are incompatible with cognitive performance requirements. In Russia, it holds pharmaceutical approval for anxiety and asthenic conditions.

Selank is available as a nasal spray through UAE Peptide Clinic. Our physicians will review your mental health history and current medications before recommending. Explore it at /peptides/selank or book a consultation at /book.